All that's happening in generics and biosimilars
Generics bulletin provides its subscribers with up-to-date commercial intelligence about business opportunities in the global generic medicines and biosimilars markets.
Accurate and reliable news reports reveal the strategies of the world’s leading generics companies and analyse their business performance, plans and product portfolios.
Patent and pricing issues, regulatory changes, government initiatives, market opportunities and industry consolidation provide the wider context for Generics bulletin’s comprehensive industry coverage.
With subscribers in nearly 60 countries, Generics bulletin is read by senior executives in all of the world’s leading generics companies, as well as by industry watchers and those supplying active ingredients, goods and services to the global generic and biosimilar medicines industries.
An annual subscription comprises:
- 46 Generics bulletin online editions – published on Fridays
- A searchable archive of more than 100 back editions dating back over five years
- 46 optional hard-copy print editions, delivered by airmail.
Choice of formats
Generics bulletin can be accessed from:
- Desktop and laptop computers AND
- Apple and Android tablets and smartphones.
Generics bulletin-i is the mobile version of Generics bulletin for Apple and Android tablet and smartphone. It is available via a FREE App from the Google Play and Apple Store. It also provides access to the searchable archive of more than 100 back editions dating back over five years.
Discounts are available for multi-user subscriptions for colleagues at the same location. Go to subscribe at the top of the screen for subscription rates.
For details of our special rates for multiple subscriptions at more than one location contact subscriptions@Generics-bulletin.com
A Corporate Subscription provides location-, country- or company-wide access to Generics bulletin. Contact subscriptions@Generics-bulletin.com for further details.